Search

Egeberg, A, L Iversen, A B Kimball, S Kelly, E Grace, H Patel, W Xu, G Gallo, E Riedl, and S R Feldman. 2022. “Pregnancy Outcomes in Patients With Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis Receiving Ixekizumab.”. The Journal of Dermatological Treatment 33 (5): 2503-9.

Kleyn, Elise, Peter S Talbot, Nehal N Mehta, Francesca Sampogna, Chris Bundy, Darren M Ashcroft, Alexa B Kimball, et al. 2020. “Psoriasis and Mental Health Workshop Report: Exploring the Links Between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.”. Acta Dermato-Venereologica 100 (1): adv00020.

Yosipovitch, Gil, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, and Alexa B Kimball. 2019. “Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis.”. Acta Dermato-Venereologica 99 (11): 1031-32.

Krueger, James G, John Frew, Gregor B E Jemec, Alexa B Kimball, Brian Kirby, Falk G Bechara, Kristina Navrazhina, et al. 2024. “Hidradenitis Suppurativa: New Insights into Disease Mechanisms and an Evolving Treatment Landscape.”. The British Journal of Dermatology 190 (2): 149-62.

Kimball, Alexa B, Errol P Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, et al. 2023. “Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial.”. Dermatology and Therapy 13 (5): 1099-1111.

Chen, Stella X, Charlotte Greif, Ruby S Gibson, Martina L Porter, and Alexa B Kimball. 2022. “Advances in Biologic and Small Molecule Therapies for Hidradenitis Suppurativa.”. Expert Opinion on Pharmacotherapy 23 (8): 959-78.

Prens, L M, M L Porter, K T Savage, P Salian, B Horváth, and A B Kimball. 2021. “Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum: A Retrospective Survey Study.”. The British Journal of Dermatology 185 (5): 1072-74.

Kimball, A B, J M Sobell, C C Zouboulis, Y Gu, D A Williams, M Sundaram, H D Teixeira, and G B E Jemec. 2016. “HiSCR (Hidradenitis Suppurativa Clinical Response): A Novel Clinical Endpoint to Evaluate Therapeutic Outcomes in Patients With Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2 Adalimumab Study.”. Journal of the European Academy of Dermatology and Venereology : JEADV 30 (6): 989-94.

Shlyankevich, Julia, Allison J Chen, Grace E Kim, and Alexandra B Kimball. 2014. “Hidradenitis Suppurativa Is a Systemic Disease With Substantial Comorbidity Burden: A Chart-Verified Case-Control Analysis.”. Journal of the American Academy of Dermatology 71 (6): 1144-50.

Sung, Sarah, and Alexa B Kimball. 2013. “Counterpoint: Analysis of Patient Claims Data to Determine the Prevalence of Hidradenitis Suppurativa in the United States.”. Journal of the American Academy of Dermatology 69 (5): 818-19.